. Current care guidelines: peripheral arterial disease. Duodecim
2010;126:1433-4.
4. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items
for systematic reviews and meta-analyses: the PRISMA statement.
BMJ 2009;339:b2535.
5. Chuter VH, Schaper N, Mills J, Hinchliffe R, Azuma N, Behrendt C,
et al. Effectiveness of bedside investigations for diagnosing peripheral artery disease among people with diabetes mellitus: a
systematic review. Diabetes Metab Res Rev 2023. [in press].
6. Chuter VH, Schaper N, Mills J, Hinchliffe R, Azuma N, Behrendt C,
et al. Performance of non-invasive bedside vascular testing in the
prediction of wound healing or amputation among people with
foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev
2023. doi: 10.1002/dmrr.3701. [Online ahead of print].
7. Chuter V, Schaper N, Mills J, Hinchliffe R, Russell D, Azuma N, et al.
Effectiveness of revascularisation for the ulcerated foot in patients
with diabetes and peripheral artery disease: A systematic review.
Diabetes Metab Res Rev 2023. doi: 10.1002/dmrr.3700. [Online
ahead of print].
8. Lucas NP, Macaskill P, Irwig L, Bogduk N. The development of a
quality appraisal tool for studies of diagnostic reliability (QAREL).
J Clin Epidemiol 2010;63:854-61.
 J, Berkman ND,
9. Sterne JA, Hern√°n MA, Reeves BC, Savovic
Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in
non-randomised studies of interventions. BMJ 2016;355:i4919.
 J, Page MJ, Elbers RG, Blencowe NS, Boutron I,
10. Sterne JA, Savovic